Catalyst Funds Management Pty »

Pliant Therapeutics shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2025-09-30 $88k 60k 1.48
2025-06-30 $40k 34k 1.16

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
NVIDIA Corp Ordinary Shares (NVDA)
Meta Platforms Ordinary Shares - Class A (META)
Microsoft Corp Ordinary Shares (MSFT)
Xtrackers Hvst CSI 300 China A-Shs ETF Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)
Rio Tinto Adr (RIO)
News Corp Ordinary Shares - Class B (NWS)
Revolution Medicines Ordinary Shares (RVMD)
Amphenol Corp Ordinary Shares - Class A (APH)
Broadcom Ordinary Shares (AVGO)
CRH Ordinary Shares (CRH)
Alphabet Ordinary Shares - Class C (GOOG)
Paramount Skydance Corp Ordinary Shares - Class B (PSKY)
JPMorgan Chase & Co Ordinary Shares (JPM)
Alphabet Ordinary Shares - Class A (GOOGL)

View all positions for Catalyst Funds Management Pty

Top funds holding Pliant Therapeutics

Tang Capital Management
Woodline Partners
Point72 Asset Management
Morgan Stanley
Blue Owl Capital Holdings
Vanguard Group
Acadian Asset Management
Citadel Advisors
Jpmorgan Chase & Co
Redmile Group
BlackRock
UBS Group
Peapod Lane Capital
Two Sigma Advisers
Renaissance Technologies

View all funds holding Pliant Therapeutics